June 11, 2020 / 2:02 AM / 21 days ago

BRIEF-Sorrento Announces It Has Submitted An Emergency Use Authorization Application For The Covi-Track Diagnostic Test

June 10 (Reuters) - Sorrento Therapeutics Inc:

* ANNOUNCES IT HAS SUBMITTED AN EMERGENCY USE AUTHORIZATION (EUA) APPLICATION FOR THE COVI-TRACK DIAGNOSTIC TEST FOR THE DETECTION OF ANTIBODIES TO SARS-COV-2

* UPON ISSUANCE OF AN EUA, COVI-TRACK TEST WILL BE AVAILABLE FOR DISTRIBUTION TO CLINICAL TESTING SITES NATIONWIDE

* SECURED MANUFACTURING CAPACITY TO SUPPORT PRODUCTION OF UP TO FIVE MILLION TEST KITS PER MONTH Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below